MOLA Cancer Inequities Symposium
2025-11-06 11:00 - 15:10 (America/Chicago)
Location: University of Texas at San Antonio – Downtown Campus – 501 W. César Chávez Blvd, San Antonio, TX
Date: Thursday, November 6th, 2025
Time: 11:00 AM – 3:10 PM
REGISTER TODAY!
Description of Event:
MOLA is pleased to present the LHS+ (Latinx,Hispanic,Spanish-speaking and related identities) cancer disparities event scheduled for Thursday, November 6th at this year’s NAMS-MOLA conference in San Antonio, TX . This academic event promises to be an enlightening and impactful gathering aimed at addressing critical issues surrounding leukemia diagnoses experienced by the LHS+ community, and fostering education, awareness, and collaboration. The series aims to connect practicing physicians, researchers, and other cancer services providing professionals and students.

Objectives:

Understanding Disparities: Recognizing and understanding the disparities faced by the LHS+ community in leukemia care, with a focus on access to novel treatments and clinical trials.
Proposing Solutions: Identifying and proposing best practices to address equity and improve health outcomes through innovative approaches.
Leveraging Community: Harnessing the unique skills, experiences, and assets of the LHS+ community, including multilingualism and cultural diversity, to overcome structural barriers and improve leukemia care outcomes.
Increasing Representation: Advocating for increased representation of LHS+ individuals in healthcare, research, and educational careers to promote better health outcomes for the LHS+ population

Target Audience: We are expecting around 500-800 LHS+ and Latinx affirming health professionals, practicing MDs in primary care and several specialties, faculty, residents, researchers, and students.

Agenda:

11:00 AM

Opening Remarks (Jonathan Moreira, MD)

11:10 AM

Keynote Speaker: Efforts to expand pathway programs for vulnerable populations in Hematology; past successes and future directions
Belinda Avalos, MD
Atrium Health
American Society of Hematology

11:40 AM

Predisposing biological factors and compounding barriers to care amongst Latino, Hispanic and Spanish speaking patients with ALL
John Molina, MD
Cleveland Clinic Foundation
Case Western Reserve University

12:10 PM – 12:15 PM

Break

12:15 PM

Dismantling barriers to access to care in the era of Tyrosine Kinase Inhibitors for chronic myelogenous leukemia
Daniela Urueta-Portillo, MD
UT Health San Antonio

12:45 PM – 2:00 PM

Lunch

2:00 PM – 2:30 PM

Allogeneic Stem Cell Transplantation: indications and barriers to transplant

25 minutes

Speaker panel/Q+A

10 minutes

Concluding Remarks

REGISTER TODAY!
